News

Last month, Par received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for dexmedetomidine HCl injection, which is indicated for sedation

The company’s lead next-generation immunotoxin compound, MT-3724, is capable of forcing internalization against the CD20 B-cell surface marker and inducing direct cell death via ribosome inactivation in CD20-expressing

The partnership will support research through the Collaborative Center for Drug Research (CCDR) as well as improve the spirit of discovery and exploration in the field of neuroscience

Initial phase of the new facility is scheduled to be opened within eight weeks, and it will be built and managed by British military engineers and medical staff.

The randomized, double-blind, multicentre trial called AMBITION, conducted in collaboration with Gilead Sciences, met the primary endpoint by showing superiority of the combination therapy compared to monotherapy treatment

The derivation process covered by the patent offers a means for commercial scale manufacturing of an allogeneic, off-the-shelf immunotherapy platform. Advanced Cell Technology president and chief executive officer

On August 13, 2014, Novartis AG filed a lawsuit against Breckenridge in the United States District Court for the District of Delaware. Breckenridge submitted its Paragraph IV ANDA

The US Food and Drug Administration (FDA) had granted clearance for Mylan’s abbreviated new drug application (ANDA) for this product, which is indicated to treat osteoporosis in postmenopausal

Under the deal, Meiji will start promotional activities for Rozerem on 01 October, targeting psychiatric institutions covered by MRs fully dedicated to the CNS field. Currently, the melatonin